Literature DB >> 15084207

Short-period heart rate variability in the general population as compared to patients with acute myocardial infarction from the same source population.

Bernhard Kuch1, Toma Parvanov, Hans W Hense, Joerg Axmann, Heinz D Bolte.   

Abstract

BACKGROUND: Our aim was to compare the distribution and determinants of heart rate variability (HRV) measures in a middle-aged population with patients of the same sex and age after an acute myocardial infarction (AMI), and to show, whether HRV values defined as abnormal from the general population are indicative for a worse prognosis even in AMI patients.
METHODS: HRV was studied in a random sample of 149 middle-aged men and 137 women from the general population (45-65 years) as well as 129 consecutive AMI patients (25-74 years). Spectral analysis was used to compute low frequency (LF), high frequency (HF), and total frequency power. To the AMI population of age 45-65 years (N = 85) a sample out of the general population was matched by age and sex by 2:1 matching (N = 149). All AMI patients were followed for a median of 43 months (range 1-47) for death or malignant arrhythmia.
RESULTS: All measures of HRV were significantly and substantially lower in AMI patients than the general population (P < 0.001). Expression in relative terms revealed that the proportionate contributions of HF and LF to total power were significantly different in the two populations with relatively lower LF power in AMI patients (P < 0.01). The negative correlation with heart rate and HRV measures was significantly more pronounced in AMI patients (P < 0.01). The 2.5th percentile of the LF power distribution in the general population (3.08 ln ms2) corresponds to the 25th percentile in the AMI population. Subjects of the whole AMI population with values below this LF cutpoint revealed a significant increased risk of death or malignant arrhythmia during follow-up (odds ratio 5.1; 95% confidence interval: 1.3; 23).
CONCLUSIONS: AMI patients had strongly diminished HRV compared to the general population. The relatively lower LF power indicates an alteration of the sympathico-vagal balance, and the significantly stronger correlation of heart rate with HRV may be indicative for a more pronounced effect of sympathetic activation on autonomic modulation in the case of myocardial infarction. Finally, a value below the 2.5th percentile of the population LF power distribution may identify subjects at risk and warrant further testing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084207      PMCID: PMC6932148          DOI: 10.1111/j.1542-474X.2004.92523.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  30 in total

1.  Circadian variation of spectral indices of heart rate variability after myocardial infarction.

Authors:  F Lombardi; G Sandrone; A Mortara; M T La Rovere; E Colombo; S Guzzetti; A Malliani
Journal:  Am Heart J       Date:  1992-06       Impact factor: 4.749

2.  Computer processing of artifact and arrhythmias in heart rate variability analysis.

Authors:  D Sapoznikov; M H Luria; Y Mahler; M S Gotsman
Journal:  Comput Methods Programs Biomed       Date:  1992 Sep-Oct       Impact factor: 5.428

3.  Frequency domain measures of heart period variability and mortality after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R C Steinman; L M Rolnitzky; R E Kleiger; J N Rottman
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

4.  Determinants of heart rate variability.

Authors:  H Tsuji; F J Venditti; E S Manders; J C Evans; M G Larson; C L Feldman; D Levy
Journal:  J Am Coll Cardiol       Date:  1996-11-15       Impact factor: 24.094

5.  Age-adjustment of HRV measures and its prognostic value for risk assessment in patients late after myocardial infarction.

Authors:  Maciej Sosnowski; Peter W MacFarlane; Zbigniew Czyz; Janina Skrzypek-Wańha; Ewa Boczkowska-Gaik; Michal Tendera
Journal:  Int J Cardiol       Date:  2002-12       Impact factor: 4.164

6.  Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials.

Authors:  M T La Rovere; G D Pinna; S H Hohnloser; F I Marcus; A Mortara; R Nohara; J T Bigger; A J Camm; P J Schwartz
Journal:  Circulation       Date:  2001-04-24       Impact factor: 29.690

7.  The defibrillator in acute myocardial infarction trial (DINAMIT): study protocol.

Authors:  S H Hohnloser; S J Connolly; K H Kuck; P Dorian; E Fain; J R Hampton; R Hatala; A C Pauly; R S Roberts; E Themeles; M Gent
Journal:  Am Heart J       Date:  2000-11       Impact factor: 4.749

8.  Sex-related differences in autonomic modulation of heart rate in middle-aged subjects.

Authors:  H V Huikuri; S M Pikkujämsä; K E Airaksinen; M J Ikäheimo; A O Rantala; H Kauma; M Lilja; Y A Kesäniemi
Journal:  Circulation       Date:  1996-07-15       Impact factor: 29.690

9.  Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study.

Authors:  H Tsuji; M G Larson; F J Venditti; E S Manders; J C Evans; C L Feldman; D Levy
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

10.  RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R C Steinman; L M Rolnitzky; W J Schneider; P K Stein
Journal:  Circulation       Date:  1995-04-01       Impact factor: 29.690

View more
  1 in total

1.  Assessment of autonomic function after acute spinal cord injury using heart rate variability analyses.

Authors:  L Malmqvist; T Biering-Sørensen; K Bartholdy; A Krassioukov; K-L Welling; J H Svendsen; A Kruse; B Hansen; F Biering-Sørensen
Journal:  Spinal Cord       Date:  2014-11-18       Impact factor: 2.772

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.